Recent Decades Saw Rise in Sedative, Hypnotic, Anxiolytic Use Disorders

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 24, 2025.

By Lori Solomon HealthDay Reporter

FRIDAY, Jan. 24, 2025 -- Diagnoses of sedative, hypnotic, or anxiolytic use disorders (SHA-UD) increased threefold to fivefold between 2001 and 2019 for adolescent and young adult U.S. Medicaid enrollees, according to a study published online Jan. 22 in Addiction.

Greta Bushnell, Ph.D., M.S.P.H., from the Rutgers Institute for Health in New Brunswick, New Jersey, and colleagues measured trends in the prevalence of SHA-UD diagnoses in adolescent (ages 13 to 17 years) and young adult (ages 18 to 29 years) U.S. Medicaid enrollees (2001 to 2019). The analysis included 5.7 (2001) to 13.2 (2019) million persons per year.

The researchers found that the prevalence of SHA-UD diagnoses significantly increased for adolescents (0.01 to 0.04 percent) and young adults (0.05 to 0.24 percent) over time. Across sex and race/ethnicity subgroups, increases were seen, with the greatest relative increases among non-Hispanic Black (624 percent) and Hispanic (529 percent) young adults. Increases in SHA-UD diagnoses were seen among those with and without a benzodiazepine, z-hypnotic, or barbiturate prescription (0.39 to 1.77 percent for young adults with a prescription; 0.03 to 0.18 percent for young adults without a prescription). Comorbid substance use disorder was seen in the majority of adolescents (76 percent) and young adults (91 percent) with an SHA-UD diagnosis in 2019.

"The increase over two decades may be attributed to changes in the availability, use, and misuse of sedative, hypnotic, and anxiolytic medications and to increased detection, awareness, and diagnosing of SHA-UD," the authors write.

Two authors disclosed testifying as an expert witness in litigation, and one author disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-01-25 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords